The involvement of BDNF and its receptor TrkB in HNSCC was first indicated by Kupferman and colleagues [16], where induction of cell migration and the epithelial–mesenchymal transition (EMT) were reported. The gene discussed is NTRK2; the disease is head and neck squamous cell carcinoma.